Edgewise Therapeutics general counsel sells over $1.9m in company stock
John R. Moore, the General Counsel of Edgewise Therapeutics, Inc. (NASDAQ:EWTX), a pharmaceutical company, has recently sold a significant amount...
John R. Moore, the General Counsel of Edgewise Therapeutics, Inc. (NASDAQ:EWTX), a pharmaceutical company, has recently sold a significant amount...
By Michael S. Derby NEW YORK (Reuters) – The central bank official responsible for implementing monetary policy at the New...
TOKYO (Reuters) – The prices Japanese companies charge each other for services rose 2.7% in August from a year earlier,...
Mexico’s economic activity rebounded strongly in July, posting a notable 3.8% growth compared to the same month last year. This...
Investing.com– U.S. stock index futures fell slightly in evening deals on Monday as Wall Street steadied near record highs, with...
Investing.com– U.S. shares of automaker Stellantis NV (NYSE:STLA) rose on Monday after the firm said it had begun searching for...
The potential takeover of Germany’s Commerzbank by Italy’s UniCredit has ignited a fierce political and economic debate, with German Chancellor...
By Nichola Groom and Lewis Jackson LOS ANGELES/SYDNEY (Reuters) -Bill Thompson’s fight to stop offshore wind farms was once confined...
By Farah Master HONG KONG (Reuters) – China’s move to raise retirement ages is a starting point to plug gaping...
The Swiss Market Index (SMI) and the Swiss franc (CHF) will be in the spotlight this week as the Swiss...